LIGAND PHARMACEUTICALS INCORPORATED Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost of $180.61 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Debt and Equity Securities › Available-for-Sale Securities, Debt Maturities › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost, Rolling Maturity
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis · last filed 2026-08-07
- 2026-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost $180.61M.
- 2026-03-31: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost $351.28M.
- 2025-09-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost $281.81M.
- 2025-06-30: Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost $136.82M.
| Period end | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Rolling within One Year, Amortized Cost |
|---|---|
| 2026-06-30 | $180.61M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $351.28M 10-Q · filed 2026-05-08 |
| 2025-09-30 | $281.81M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $136.82M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $124.95M 10-Q · filed 2025-05-09 |
| 2024-09-30 | $91.07M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $62.95M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $109.61M 10-Q · filed 2024-05-08 |
| 2023-09-30 | $71.09M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $89.25M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $123.79M 10-Q · filed 2023-05-08 |
| 2022-09-30 | $8.66M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $6.42M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $10.10M 10-Q · filed 2022-05-09 |
| 2021-09-30 | $76.06M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $58.00M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $77.91M 10-Q · filed 2021-05-06 |
| 2020-09-30 | $121.45M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $414.50M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $401.34M 10-Q · filed 2020-05-08 |